GMNN Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant GMNN.
- 产品详情
- 实验流程
Application ![]()
| WB, IHC, IF, E |
---|---|
Primary Accession | O75496 |
Other Accession | BC005185 |
Reactivity | Human |
Host | mouse |
Clonality | monoclonal |
Isotype | IgG1 Kappa |
Clone Names | 1A8 |
Calculated MW | 23565 Da |
Gene ID | 51053 |
---|---|
Other Names | Geminin, GMNN |
Target/Specificity | GMNN (AAH05185, 110 a.a. ~ 209 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
Dilution | WB~~1:500~1000 IHC~~1:100~500 IF~~1:50~200 E~~N/A |
Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
Precautions | GMNN Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
REFERENCES
Variation at the NFATC2 Locus Increases the Risk of Thiazolinedinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study. Bailey SD, et al. Diabetes Care, 2010 Jul 13. PMID 20628086.Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Talmud PJ, et al. Am J Hum Genet, 2009 Nov. PMID 19913121.Quaternary structure of the human Cdt1-Geminin complex regulates DNA replication licensing. De Marco V, et al. Proc Natl Acad Sci U S A, 2009 Nov 24. PMID 19906994.Selective killing of cancer cells by suppression of geminin activity. Zhu W, et al. Cancer Res, 2009 Jun 1. PMID 19487297.Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. Enjuanes A, et al. Cancer Res, 2008 Dec 15. PMID 19074885.

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.